Amoéba S.A. (EPA:ALMIB)
France · Delayed Price · Currency is EUR 0.9480
+0.0810 (9.34%)
Aug 13, 2025, 5:35 PM CET
Amoéba Company Description
Amoéba S.A. develops biological products and services for the treatment of microbiological risk in the sectors of water, health, and plant protection.
It has developed technology to treat water, surfaces, and chronic wounds that uses the natural biocidal capacity of the living amoeba Willaertia magna C2c Maky; and agriculture biocontrol technology for the treatment of phytopathogenic microorganisms using the lysed.
The company was incorporated in 2010 and is based in Chassieu, France.
Amoéba S.A.
| Country | France |
| Founded | 2010 |
| Industry | Agricultural Inputs |
| Sector | Materials |
| Employees | 20 |
| CEO | Jean-Francois Doucet |
Contact Details
Address: 38 Avenue des FrEres Montgolfier Chassieu, 69680 France | |
| Phone | 33 4 26 69 16 00 |
| Website | amoeba-nature.com |
Stock Details
| Ticker Symbol | ALMIB |
| Exchange | Euronext Paris |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| ISIN Number | FR0011051598 |
| SIC Code | 2890 |
Key Executives
| Name | Position |
|---|---|
| Jean-Francois Doucet | General Director |
| Dr. Sandrine Troussieux | Scientific Director |